Science Explorer Interactive view Map
Company · Colombes · France

UCB Pharma (France)

Research works
65
▼ 34% vs 2013–17
Citations
1.2k
18.5 per fractional work
Top-10% rate
15.7%
record average 16.5%
Open access
45%
world 28%

Not ranked overall: UCB Pharma (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.27× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 15.53× its world share, 4 worksImmunology and Micro…Neuroscience: 0.43× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.24× its world share, 0 worksPharmacology, Toxico…Earth and Planetary Sciences: 0.24× its world share, 0 worksEarth and Planetary …Engineering: 0.01× its world share, 0 worksEngineeringMathematics: 0.32× its world share, 0 worksMathematicsPhysics and Astronomy: 0.03× its world share, 0 worksPhysics and AstronomyHealth Professions: 1.20× its world share, 1 worksHealth ProfessionsMedicine: 3.67× its world share, 16 worksMedicineNursing: 1.11× its world share, 0 worksNursingDecision Sciences: 0.39× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 2.70× its world share, 1 worksEconomics, Econometr…Psychology: 0.17× its world share, 0 worksPsychologySocial Sciences: 0.02× its world share, 0 worksSocial Sciencesworld share
more than its size predictsabout as predictedless

Rings at 0.5×, and 2×. Widest outward: Immunology and Microbiology, 15.5×. Every wedge is a field page.

Who are the top researchers at UCB Pharma (France)?

Ranked on the composite score, Jérémy Lambert, Jean-Michel Joubert and V. Taieb lead among researchers whose main affiliation is UCB Pharma (France).

  1. 1 Jérémy Lambert France · #580,026 worldwide 76 citations · 15 works
  2. 2 Jean-Michel Joubert France · #1,467,865 worldwide 6 citations · 17 works
  3. 3 V. Taieb France · #1,537,128 worldwide 1 citations · 31 works
All ranked researchers at UCB Pharma (France)

Which keywords describe research at UCB Pharma (France)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Autoantibodies, Quality of Life, Inflammation, IL-17, TH17 Cells, Ankylosing Spondylitis, Spondyloarthritis and Rheumatoid Arthritis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 21 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Autoantibodies4▲ 68×6 topics
  2. Quality of Life4▲ 11×4 topics
  3. Inflammation3▲ 7.5×7 topics
  4. Ankylosing Spondylitis3▲ 494×1 topic
  5. IL-173▲ 409×1 topic
  6. Spondyloarthritis3▲ 494×1 topic
  7. TH17 Cells3▲ 409×1 topic
  8. Rheumatoid Arthritis2▲ 117×2 topics
  9. Epidemiology2▲ 2.8×10 topics
  10. Biological Therapy2▲ 184×1 topic
  11. Cytokines2▲ 37×2 topics
  12. Disease-Modifying Antirheumatic Drugs2▲ 207×1 topic
  13. Immunosuppressive Therapy2▲ 43×3 topics
  14. Acne Inversa2▲ 744×1 topic
  15. Hidradenitis Suppurativa2▲ 744×1 topic
  16. Treatment2▲ 6.0×5 topics
  17. Prognosis2▲ 21×3 topics
  18. Cost-effectiveness Analysis1▲ 64×1 topic
  19. Health Utility Measures1▲ 64×1 topic
  20. Pathogenesis1▲ 10×4 topics
  21. Neurological Disorders1▲ 8.7×4 topics

Which research topics does UCB Pharma (France) publish most on?

By volume in 2022–2025: Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis, Rheumatoid Arthritis Research and Therapies and Hidradenitis Suppurativa and Treatments.

  1. 1 Spondyloarthritis Studies and Treatments Rheumatology 3 works
  2. 2 Psoriasis: Treatment and Pathogenesis Immunology 3 works
  3. 3 Rheumatoid Arthritis Research and Therapies Rheumatology 2 works
  4. 4 Hidradenitis Suppurativa and Treatments Dermatology 2 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  6. 6 Myasthenia Gravis and Thymoma Neurology 1 works
  7. 7 Peripheral Neuropathies and Disorders Neurology 1 works
  8. 8 Fibromyalgia and Chronic Fatigue Syndrome Research Psychiatry and Mental health 0 works
  9. 9 Acne and Rosacea Treatments and Effects Dermatology 0 works
  10. 10 Coagulation, Bradykinin, Polyphosphates, and Angioedema Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.8%not open55.2%

World: 28% of research is openly available.

with international co-authors57.8%domestic only42.2%

World: 19% is written across borders.

How has UCB Pharma (France)'s research output changed?

Output in 2018–2022 was 34% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Colombes

All research institutions in Colombes

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.